Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Scott D Halpern, MD PhD
University of Pennsylvania
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kaiser Permanente Southern California
Oakland, California, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Geisinger
Danville, Pennsylvania, United States
- Lancaster General Health
Lancaster, Pennsylvania, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 May 2021
- Primary completion
- 4 Nov 2024
- Completion
- 29 Apr 2025
- Last update posted
- 25 Feb 2026
- Registered enrollment
- 3,228
- Registry id
- NCT04798664
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.